CY1106234T1 - Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus - Google Patents

Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus

Info

Publication number
CY1106234T1
CY1106234T1 CY20061101586T CY061101586T CY1106234T1 CY 1106234 T1 CY1106234 T1 CY 1106234T1 CY 20061101586 T CY20061101586 T CY 20061101586T CY 061101586 T CY061101586 T CY 061101586T CY 1106234 T1 CY1106234 T1 CY 1106234T1
Authority
CY
Cyprus
Prior art keywords
compositions
treatment
staphylococcus aureus
aureus infections
infections
Prior art date
Application number
CY20061101586T
Other languages
English (en)
Inventor
Naomi Balaban
James W. Larrick
Susan C. Wright
Original Assignee
Naomi Balaban
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Naomi Balaban filed Critical Naomi Balaban
Publication of CY1106234T1 publication Critical patent/CY1106234T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Παρέχονται μέθοδοι και συνθέσεις για την θεραπεία σταφυλοκοκκικών μολύνσεων.
CY20061101586T 1997-12-19 2006-11-02 Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus CY1106234T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6809497P 1997-12-19 1997-12-19
US09/054,331 US6291431B1 (en) 1997-12-19 1998-04-02 Methods and compositions for the treatment and prevention of Staphylococcal infections
PCT/US1998/027091 WO1999032133A1 (en) 1997-12-19 1998-12-18 Methods and compositions for the treatment and prevention of staphylococcus aureus infections

Publications (1)

Publication Number Publication Date
CY1106234T1 true CY1106234T1 (el) 2011-06-08

Family

ID=26732900

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061101586T CY1106234T1 (el) 1997-12-19 2006-11-02 Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus

Country Status (10)

Country Link
US (2) US6291431B1 (el)
EP (1) EP1037650B1 (el)
AT (1) ATE335499T1 (el)
AU (1) AU2005099A (el)
CY (1) CY1106234T1 (el)
DE (1) DE69835536T2 (el)
DK (1) DK1037650T3 (el)
ES (1) ES2270540T3 (el)
PT (1) PT1037650E (el)
WO (1) WO1999032133A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6703374B1 (en) 1997-10-30 2004-03-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleosides for imaging and treatment applications
US20080219976A1 (en) * 1997-12-19 2008-09-11 Naomi Balaban Methods and compositions for treatment and prevention of staphylococcal infections
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections
US7323179B2 (en) * 1997-12-19 2008-01-29 Naomi Balaban Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections
US7534857B2 (en) * 1997-12-19 2009-05-19 Centegen, Inc. Methods and compositions for the treatment and prevention of staphylococcal infections
EP1862549A3 (en) * 1998-09-15 2008-02-13 Naomi Balaban Target of RNAIII activating protein (TRAP)
EP1188831B1 (en) * 1998-09-15 2007-12-05 Naomi Balaban Target of RNAIII activating protein (TRAP)
JP2003522153A (ja) * 2000-02-10 2003-07-22 インターミューン インコーポレイテッド ブドウ球菌属ビルレンスの新規アミノ酸インヒビターおよびペプチドインヒビター
US6984381B2 (en) 2002-07-05 2006-01-10 The United States Of America As Represented By The Secretary Of Agriculture Vaccine for the prevention of bacterial infection of the bovine mammary gland
CN1569889A (zh) * 2003-07-21 2005-01-26 中国人民解放军军事医学科学院基础医学研究所 能与金葡菌自分泌的rnaiii激活蛋白结合的环多肽及其医药用途
EP1621203A1 (en) * 2004-07-27 2006-02-01 Genoscience RNAIII-inhibiting peptides for treating HIV infection
US7824691B2 (en) * 2005-04-04 2010-11-02 Centegen, Inc. Use of RIP in treating staphylococcus aureus infections
US20070015685A1 (en) * 2005-04-04 2007-01-18 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070092572A1 (en) * 2005-04-04 2007-04-26 Naomi Balaban Bone cement compositions and the like comprising an RNAIII-inhibiting peptide
US20070009566A1 (en) * 2005-04-04 2007-01-11 Naomi Balaban Method and apparatus for treating bacterial infections in devices
CN101189020A (zh) * 2005-05-10 2008-05-28 N·巴拉班 用于给予rnaⅲ-抑制肽的组合物
WO2007061942A2 (en) 2005-11-18 2007-05-31 Glanbia Nutritionals (Ireland) Ltd. Compositions for disrupting and inhibiting reconstitution of wound biofilm
WO2007090123A2 (en) * 2006-01-30 2007-08-09 University Of Chicago Mgra is a redox regulator of antibiotic sensitivity and virulence
WO2007147098A2 (en) * 2006-06-16 2007-12-21 Tufts University Identification and use of non-peptide analogs of rnaiii-inhibiting peptide for the treatment of staphylococcal infections
WO2008129428A2 (en) * 2007-04-19 2008-10-30 Molecular Detection Inc. Methods, compositions and kits for detection and analysis of antibiotic-resistant bacteria
US9777076B2 (en) 2012-07-16 2017-10-03 Pfizer Inc. Saccharides and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3043362B2 (ja) 1989-04-27 2000-05-22 マクニール―ピーピーシー・インコーポレーテツド タンポンへの添加剤
AU3825995A (en) 1994-10-04 1996-04-26 New York University Blocking expression of virulence factors in s. aureus
AU735283B2 (en) 1996-05-22 2001-07-05 New York University Blocking expression of virulence factors in (s. aureus)
US6291431B1 (en) 1997-12-19 2001-09-18 Panorama Research Methods and compositions for the treatment and prevention of Staphylococcal infections

Also Published As

Publication number Publication date
EP1037650B1 (en) 2006-08-09
WO1999032133A1 (en) 1999-07-01
US7067135B2 (en) 2006-06-27
DK1037650T3 (da) 2006-12-11
PT1037650E (pt) 2006-12-29
ES2270540T3 (es) 2007-04-01
US6291431B1 (en) 2001-09-18
DE69835536T2 (de) 2007-08-09
EP1037650A1 (en) 2000-09-27
US20040077534A1 (en) 2004-04-22
ATE335499T1 (de) 2006-09-15
EP1037650A4 (en) 2004-10-20
DE69835536D1 (de) 2006-09-21
AU2005099A (en) 1999-07-12

Similar Documents

Publication Publication Date Title
CY1106234T1 (el) Συνθεσεις για τη θepαπεια μολυνσεων staphylococcus aureus
DE60131138D1 (de) Antibakterielle mittel
ES2184149T3 (es) Paclitaxeles 6-tio sustituidos.
PT618190E (pt) 9-¬glicil substituido)amido|-6-(substituido)-5-hidroxi-6-desoxitetraciclinas
RS50005B (sr) Novi oblik s-omeprazola
DE69319976T2 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
FI20050238A (fi) Markfortiini- ja paraherkvamidiyhdisteet
UY26380A1 (es) Inhibidores de fab i
ES2161220T3 (es) 9-((glicil sustituido)amido)-6-desmetil-6-desoxitetraciclinas como agentes antibioticos.
DE69625515D1 (de) Benzooxazine als antimikrobielle mittel
PT1216256E (pt) Antibioticos macrolidos e tratamento de pasteurelose
DE69928384D1 (de) Behandlung und nachweis von staphylokokkeninfektionen
TR199901209T2 (xx) B�cek �ld�r�c� ve mitisidal kompozisyonlar
DK1073447T3 (da) N1-modificerede glycopeptider
FI951655A0 (fi) H.pylori -infektioiden hoito
DE69620313D1 (de) Als antimikrobielles Mittel verwendbare Zusammensetzung
NO976070L (no) Felteffekttransistor
DE60141994D1 (de) 13-substituierte Methacyclinverbindungen
RU96117132A (ru) Антибактериальное средство - родиола розовая
DE60235538D1 (de) Glycopeptid-antibiotika
ATE478155T1 (de) Glycopeptidantibiotika
IT1267343B1 (it) Composizione insetticida.
ES1025316Y (es) Ambientador mejorado.
DE69311093D1 (de) Feldeffekttransistor
CY2012008I1 (el) 8α-αζαλιδες ως κτηνιατρικα αντιμικροβιακα μεσα